|
NINGBO OUMAN PHARM CO LTD
|
About Us
The company NINGBO OUMAN BIOTECH CO.,LTD now owns more than 200000 square meters of land and 30000 square meters of plant area, which has been put into research and development With a production cost of more than 20 million yuan, it has a first-class production line and technical personnel.The workshop Designed and built according to GMP requirements, it is actively obtaining GMP certification. The company has After applying for invention patents and trademarks, it has more than 20 personnel with bachelor degree or above and 10 engineers More than, with more than 80 employees.
It has branches in more than 30 provinces, municipalities and autonomous regions in China, and 40 subsidiaries overseas. There are nearly 10,000 employees worldwide, of which R & D personnel account for more than 20%, and foreign employees account for more than 12%, from more than 30 countries and regions around the world, forming a huge global R & D, marketing and service network. The main business covers the three major fields of life information and support, in vitro diagnosis, and medical imaging. Through cutting-edge technological innovation, it provides more complete product solutions to help the world improve medical conditions and improve the rate of diagnosis and treatment.
Company Profile
| Year Company Established: | 2014-07-23 |
| Annual Sales Amount: | US$5 – 10 Million |
| Total No. of Staff: | 101 – 500 People |
| No. of R&D Staff: | 11 – 20 People |
| No. of Engineers: | 11 – 20 People |
| Export Ratio: | 21% – 30% |
| OEM Services Provided: | YES |
| Payment Terms: | T/T, L/C, D/A, D/P, WU |
| Business Type: | Manufacturer |
| Quality Certificate: | ISO9001, FDA, SSA, RoHS |
| Main Export Markets: | North America, Western Europe, Eastern Europe, South America, Southeast Asia, Eastern Asia, Mid East, Oceania, Africa |
| Competitive Advantage: |
It has branches in more than 30 provinces, municipalities and autonomous regions in China, and 40 subsidiaries overseas. There are nearly 10,000 employees worldwide, of which R & D personnel account for more than 20%, and foreign employees account for more than 12%, from more than 30 countries and regions around the world, forming a huge global R & D, marketing and service network. |
